382 related articles for article (PubMed ID: 32850308)
41. Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment.
Gentilal N; Abend E; Naveh A; Marciano T; Balin I; Telepinsky Y; Miranda PC
Front Hum Neurosci; 2022; 16():931818. PubMed ID: 35898934
[TBL] [Abstract][Full Text] [Related]
42. Acceptance and compliance of TTFields treatment among high grade glioma patients.
Onken J; Staub-Bartelt F; Vajkoczy P; Misch M
J Neurooncol; 2018 Aug; 139(1):177-184. PubMed ID: 29644485
[TBL] [Abstract][Full Text] [Related]
43. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
Tanzhu G; Chen L; Xiao G; Shi W; Peng H; Chen D; Zhou R
Cell Death Discov; 2022 Oct; 8(1):416. PubMed ID: 36220835
[TBL] [Abstract][Full Text] [Related]
44. The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
Glas M; Ballo MT; Bomzon Z; Urman N; Levi S; Lavy-Shahaf G; Jeyapalan S; Sio TT; DeRose PM; Misch M; Taillibert S; Ram Z; Hottinger AF; Easaw J; Kim CY; Mohan S; Stupp R
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1269-1278. PubMed ID: 34963556
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort.
She L; Gong X; Su L; Liu C
Front Neurol; 2022; 13():1042888. PubMed ID: 36698900
[TBL] [Abstract][Full Text] [Related]
46. Tumor treating fields with radiation for glioblastoma: a narrative review.
Miller R; Niazi M; Russial O; Poiset S; Shi W
Chin Clin Oncol; 2022 Oct; 11(5):40. PubMed ID: 36336899
[TBL] [Abstract][Full Text] [Related]
47. Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors.
Benson L
Semin Oncol Nurs; 2018 May; 34(2):137-150. PubMed ID: 29631935
[TBL] [Abstract][Full Text] [Related]
48.
Blatt R; Davidi S; Munster M; Shteingauz A; Cahal S; Zeidan A; Marciano T; Bomzon Z; Haber A; Giladi M; Weinberg U; Kinzel A; Palti Y
Front Oncol; 2021; 11():670809. PubMed ID: 34249709
[TBL] [Abstract][Full Text] [Related]
49. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
[TBL] [Abstract][Full Text] [Related]
50. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
51. Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma.
Vymazal J; Kazda T; Novak T; Slanina P; Sroubek J; Klener J; Hrbac T; Syrucek M; Rulseh AM
Front Oncol; 2022; 12():1014455. PubMed ID: 36741707
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.
Olatunji G; Aderinto N; Adefusi T; Kokori E; Akinmoju O; Yusuf I; Olusakin T; Muzammil MA
Medicine (Baltimore); 2023 Dec; 102(48):e36421. PubMed ID: 38050252
[TBL] [Abstract][Full Text] [Related]
53. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.
Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D
Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030
[TBL] [Abstract][Full Text] [Related]
54. Modeling Tumor Treating fields (TTFields) application within a realistic human head model.
Wenger C; Salvador R; Basser PJ; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2555-8. PubMed ID: 26736813
[TBL] [Abstract][Full Text] [Related]
55. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
Shams S; Patel CB
J Mol Cell Biol; 2022 Dec; 14(8):. PubMed ID: 35973687
[TBL] [Abstract][Full Text] [Related]
56. Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
Voloshin T; Schneiderman RS; Volodin A; Shamir RR; Kaynan N; Zeevi E; Koren L; Klein-Goldberg A; Paz R; Giladi M; Bomzon Z; Weinberg U; Palti Y
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080774
[TBL] [Abstract][Full Text] [Related]
57. Tumor treating fields: concept, evidence and future.
Pless M; Weinberg U
Expert Opin Investig Drugs; 2011 Aug; 20(8):1099-106. PubMed ID: 21548832
[TBL] [Abstract][Full Text] [Related]
58. Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment.
Carrieri FA; Smack C; Siddiqui I; Kleinberg LR; Tran PT
Front Oncol; 2020; 10():575992. PubMed ID: 33215030
[TBL] [Abstract][Full Text] [Related]
59. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
[TBL] [Abstract][Full Text] [Related]
60. Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
Guzauskas GF; Salzberg M; Wang BC
CNS Oncol; 2018 Jul; 7(3):CNS23. PubMed ID: 30124334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]